Kang Leaving CMS For CIGNA; Agency Begins Search For Replacement
This article was originally published in The Gray Sheet
Robert Streimer is expected to take over as interim acting director of Office of Clinical Standards & Quality at the Centers for Medicare & Medicaid Services when current director Jeffrey Kang, MD steps down in early May
You may also be interested in...
The HHS Secretary's Advisory Committee on Genetic Testing is asking the Institute of Medicine to issue a report on the role of genetic counseling and education in securing private coverage and Medicare reimbursement for genetic tests
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.